This report was first published by Endpoints News. To see the original version, click here
Uğur Şahin and Özlem Türeci are set to leave BioNTech by the end of the year and establish a new company dedicated to next-generation mRNA innovations.
BioNTech itself will narrow its focus to its late-stage pipeline, and the hunt is on to find a new leadership team.
您已阅读7%（356字），剩余93%（4588字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。